Health

What Is Metabolic Dysfunction-Associated Steatotic Liver Disease?

[ad_1]

Metabolic dysfunction–associated steatotic liver disease (MASLD) is the accumulation of fat in the liver caused by a buildup of fat in the body. It’s a chronic liver disease, affecting almost 1 out of 4 people in the United States, according to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

While it’s normal and healthy for the liver to contain some fat, if more than 5 to 10 percent of the liver’s weight is fat, it’s called a fatty liver, also known as steatosis.

Previously referred to as nonalcoholic fatty liver disease (NAFLD), MASLD was renamed in 2023 to better reflect its causes and avoid stigmatizing language to those affected by the condition.

When inflammation and liver cell damage occur along with fat in the liver, it’s called metabolic dysfunction–associated steatohepatitis (MASH). Per the NIDDK, MASH is a type of nonalcoholic fatty liver disease, and it affects about 1 out of 5 people with MASLD.

According to a review in the World Journal of Gastroenterology, it’s estimated that by 2030, MASH may be the No. 1 reason for liver transplants in the United States.

Metabolic Dysfunction–Associated Steatotic Liver Disease vs. Alcohol-Associated Liver Disease

MASLD and alcohol-associated liver disease are the two most common forms of chronic liver disease in the United States right now, according to Christina Lindenmeyer, MD, a gastroenterologist at the Cleveland Clinic in Ohio.

The primary difference is indicated in the names of the diseases: Alcohol-associated liver disease is linked with alcohol ingestion, and metabolic dysfunction–associated steatotic liver disease is associated with metabolic syndrome — a group of health risks that includes obesity, high cholesterol, high blood pressure, high blood sugar, and a large waistline — says Dr. Lindenmeyer.

[ad_2]

Related Articles

Leave a Reply

Back to top button